Paroxetine for the treatment of depression: a critical update.
about
Paroxetine versus other anti-depressive agents for depressionA comparative review of escitalopram, paroxetine, and sertraline: Are they all alike?Paroxetine-mediated GRK2 inhibition reverses cardiac dysfunction and remodeling after myocardial infarctionPossible impact of the CYP2D6*10 polymorphism on the nonlinear pharmacokinetic parameter estimates of paroxetine in Japanese patients with major depressive disorders.Cytochrome P450 2D6 genotype affects the pharmacokinetics of controlled-release paroxetine in healthy Chinese subjects: comparison of traditional phenotype and activity score systems.The influence of paroxetine on the pharmacokinetics of atomoxetine and its main metabolite.
P2860
Paroxetine for the treatment of depression: a critical update.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Paroxetine for the treatment of depression: a critical update.
@en
Paroxetine for the treatment of depression: a critical update.
@nl
type
label
Paroxetine for the treatment of depression: a critical update.
@en
Paroxetine for the treatment of depression: a critical update.
@nl
prefLabel
Paroxetine for the treatment of depression: a critical update.
@en
Paroxetine for the treatment of depression: a critical update.
@nl
P2860
P1476
Paroxetine for the treatment of depression: a critical update.
@en
P2093
Sara Gibiino
P2860
P304
P356
10.1517/14656566.2012.652085
P407
P577
2012-01-21T00:00:00Z